NEW YORK (GenomeWeb News) — Shares in Gene Logic were down 15.47 percent, or $.30, at $1.64 in midday trading after the company this morning said third-quarter revenue slid 39 percent, and that it plans to sell its preclinical services division.
 
After stating in September that the preclinical services segment would not be put on the block, today Gene Logic said it has hired an investment firm to help it divest the unit, and is currently in discussions for the sale.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.